Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Tecan Launches New Options for Cavro® Omni Robot
Wednesday, July 16, 2014
Cavro Omni Robot Version 4.0 launched at the AACC’s 2014 Clinical Lab Expo.

High Throughput Screening of Novel Protein Therapeutics
Tuesday, July 15, 2014
INTEGRA VIAFLO 96 - a handheld 96-channel electronic pipette.

Compact Sample Concentrator for R&D Departments
Tuesday, July 15, 2014
MiniVap™ blowdown sample concentrator from Porvair Sciences.

ChromaTrap™ Helps Advance Research into Women`s Reproductive Health
Wednesday, July 09, 2014
Latest research developments in women’s reproductive health using molecular biology tools.

OGT Launches High-Resolution, High-throughput PGS Array
Wednesday, July 09, 2014
Confident genome-wide aneuploidy detection in 14 samples on a single array.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

BioTek Launches Enhanced SiLA Compliant Software
Tuesday, July 08, 2014
BioTek’s LHC™ SiLA software for washers/dispensers.

Revolutionary Transfer Tool for Automated Nested LiHa Disposable Tip Handling
Tuesday, July 08, 2014
The device from Tecan offers increased throughput and capacity for Freedom EVO® workstations.

New Epoch™ 2 Microplate Spectrophotometer from BioTek
Thursday, July 03, 2014
Provides enhanced user interface for spectral absorbance detection.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 2602
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv